The Validity of a Continuous Glucose Monitor in Diagnosing Gestational Diabetes: A Pilot Study
Status: Recruiting
Location: See all (2) locations...
Intervention Type: Device
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY
This is a prospective pilot study to assess the validity of using a continuous glucose monitor (CGM) in diagnosing gestational diabetes mellitus (GDM). Pregnant individuals between the ages of 18-50 years old receiving prenatal care at Mount Sinai Hospital (e..g, E-Level clinic and Faculty Practice Associates) will be enrolled. Potential participants will be approached during their prenatal care appointments. Participants will complete an informed consent form for the study during their standard-of-care prenatal appointments at our institution.
Eligibility
Participation Requirements
Sex: Female
Minimum Age: 18
Maximum Age: 50
Healthy Volunteers: t
View:
• Ages 18-50
• Singleton pregnancy between 24-32 weeks gestational age
• Prenatal care and delivery at Mount Sinai Hospital
Locations
United States
New York
Icahn School of Medicine at Mount Sinai
RECRUITING
New York
Mount Sinai South Nassau
NOT_YET_RECRUITING
Oceanside
Contact Information
Primary
Nicola F Tavella, MPH
nicola.tavella@mssm.edu
212-241-3888
Backup
Victoria Ly, MD
victoria.ly@mssm.edu
212-241-5681
Time Frame
Start Date: 2025-10-02
Estimated Completion Date: 2028-04
Participants
Target number of participants: 150
Treatments
Experimental: Individuals receiving prenatal care at Mount Sinai Hospital
Women receiving prenatal care at Mount Sinai Hospital to have 10-day application of continuous glucose monitor
Related Therapeutic Areas
Sponsors
Leads: Icahn School of Medicine at Mount Sinai